Search General Info
Search Education
Search Partnering Companies
New sessions, presentations, and speakers added regularly, so check back frequently for updates.
Please note: all times listed below are Pacific Time, PDT.
BIO Digital
Date
Time
Search Sessions
BIO Digital
Available On-Demand
As the industry continues its shift from volume to value, stakeholders are increasingly relying on…
While the impact of cardiovascular disease remains a major cause of mortally and morbidity, not…
While artificial intelligence (AI) is providing meaningful advances across different industries,…
The healthtech marketplace is one where few companies have a majority control of the distribution…
Millions of people around the world are impacted by neurodegenerative diseases— the two most common…
Iinnovation in the development of vaccines is not just limited to the vaccine itself. Over the last…
The number and kind of global infectious disease outbreaks have increased significantly during the…
Precision medicine was supposed to deliver more targeted, personalized treatment to all patients —…
Commercially available CAR-T products such as Yescarta and Kymriah have shown the power of cell…
Innovative medicines are increasingly coming to market with new modalities authorized under new…
Is there a secret recipe for successful partnerships between founders and their investment partners…
Many of the 7,000 rare diseases worldwide lack a standardized diagnostic test. Without a reliable…
The CNS drug field has been hampered by trial failures in areas of substantial unmet medical need…
While most of the attention in the use of digital health for chronic care management has gone to…
Genomics is at an inflection point. Dramatic declines in the cost of sequencing combined with…
Damage caused by opioid misuse and addiction reaches across every domain, from lost productivity…
Initiatives to reduce opioid prescription and opiod use are in force, but the need for effective…
The diverse panelists will lead a discussion of why and how to continue to increase inclusion and…
The repurposing of existing drugs is an established approach to develop new treatment options for…
Threats to U.S. technology from foreign sources have been in the news recently with reports of…
Value based contracting approaches, which need to be informed by real-world evidence, become…
Dr. Phil Febbo was appointed as Chief Medical Officer in March 2018. In this role, he is…
Bioartificial organs have become viable therapies for life threatening diseases thanks to new…
Panelists will feature academics and industry thought leaders as they share their expertise in…
What if patients were not patients anymore? For companies developing gene therapies for rare…
Genomic medicine is already heralding a new era of healthcare, bringing fresh hope to patients as…
As the promise of innovation reveals to us a future of more targeted therapies, advanced biologics…
With thousands of cancer drugs in the pipeline, and oncology drugs dominating annual lists of top…
Bio/pharma transactions come in all shapes and sizes but each will have some element of IP due…
In oncology, going beyond the current standard of care will require increasingly potent therapies -…
Bio/pharma companies negotiate and enter into a multiplicity of contracts as a key part of company…
The liquid biopsy market is expected to grow to as much as $30 billion by 2025. Many factors are…
Biologics have revolutionized treatment for serious diseases and profoundly impacted millions of…
The COVID-19 pandemic has stretched the limits of pharmaceutical development and manufacturing due…
Cries for economic reform to halt the collapse of the antibiotics market have never been louder. As…
Small businesses are constantly on the lookout for funding opportunities to meet their development…
Biotechnology companies face multiple risks which, if not properly managed, can threaten their…
Congress and the White House have seemed at odds on many positions but united in at least one –…
It is well documented that clinical trials in the U.S. lack appropriate diverse representation…
In the first three quarters of 2019, drug developers pledged to spend $182bn on M&A, beating the…
“The microbiome” is everywhere in the press and fast-increasing resources are devoted to it in labs…
The rise of Chinese bio and pharma companies has provided many US and European companies with the…
Big Pharma and investors are closely watching the precision oncology space. From 2015 through 2019,…
Mitochondria are known as the powerhouses and energy hubs of the cell. Mostly relegated to biology…
The field of immuno-oncology has grown exponentially, leading to a host of new therapeutics being…
The human microbiome is considered as the “new organ”, thought to be associated with multiple…
The shortcomings of animal disease models are well known. More than 90% of drugs fail in early…
In times of the Covid-19 pandemic, Biotech- and Pharmaindustry and public institutions are working…
Cell and gene therapy (CGT) offers new hope for patients. There are essential differences between…
The DTx market has grown more than 50% over the last 3 years, with many new technologies entering…
Cell and gene therapies are transforming patients’ lives and payment models. This panel explores…
In oncology, precision medicine is leading a paradigm shift away from a “one size fits all”…
Bring a team of behavioral/neurobiology, neuroepigeneticists, and psychiatry clinician to discuss…
Cures to devastating diseases, such as Hepatitis C drugs and gene therapies, are being developed…
The latest UN estimates show men slightly outnumber women globally, but the future of biopharma is…
What if we could halt or reverse the diseases associated with aging and extend the amount of…
What is driving/sustaining the widest and longest-open IPO window, with 350 newly-public companies?…
Ongoing innovation is needed to address the growing threat of antimicrobial resistance. The current…
The role of the biotechnology sector in addressing global challenges has become clear during the…
Six of the top ten biggest selling biopharmaceuticals were acquired or in-licensed. In parallel,…
Since their inception, biotech incubators and accelerators have matured in the resources offered to…
With digital health, we strive to improve patient outcomes by uncovering actionable insights…
In view of burgeoning healthcare needs, most governments aspire to reduce their healthcare expense…
In its 40-year lifetime, the HIV epidemic has shifted from a death sentence to a manageable…
In parallel to videoconference presentation tips, the power of delivering the right content is ever…
For more than a decade governments, thought leaders and industry have called for but questioned the…
For many patients with blood cancers and serious blood disorders, bone marrow transplant can be a…
There is no shortage of innovation in the biotechnology industry, with stunning advances in…
Patents are key assets of bio/pharma companies. At every step that a company takes - from the time…
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
